Mask-guided cross-image attention for zero-shot in-silico histopathologic image generation with a diffusion model
Authors:
Dominik Winter,
Nicolas Triltsch,
Marco Rosati,
Anatoliy Shumilov,
Ziya Kokaragac,
Yuri Popov,
Thomas Padel,
Laura Sebastian Monasor,
Ross Hill,
Markus Schick,
Nicolas Brieu
Abstract:
Creating in-silico data with generative AI promises a cost-effective alternative to staining, imaging, and annotating whole slide images in computational pathology. Diffusion models are the state-of-the-art solution for generating in-silico images, offering unparalleled fidelity and realism. Using appearance transfer diffusion models allows for zero-shot image generation, facilitating fast applica…
▽ More
Creating in-silico data with generative AI promises a cost-effective alternative to staining, imaging, and annotating whole slide images in computational pathology. Diffusion models are the state-of-the-art solution for generating in-silico images, offering unparalleled fidelity and realism. Using appearance transfer diffusion models allows for zero-shot image generation, facilitating fast application and making model training unnecessary. However current appearance transfer diffusion models are designed for natural images, where the main task is to transfer the foreground object from an origin to a target domain, while the background is of insignificant importance. In computational pathology, specifically in oncology, it is however not straightforward to define which objects in an image should be classified as foreground and background, as all objects in an image may be of critical importance for the detailed understanding the tumor micro-environment. We contribute to the applicability of appearance transfer diffusion models to immunohistochemistry-stained images by modifying the appearance transfer guidance to alternate between class-specific AdaIN feature statistics matchings using existing segmentation masks. The performance of the proposed method is demonstrated on the downstream task of supervised epithelium segmentation, showing that the number of manual annotations required for model training can be reduced by 75%, outperforming the baseline approach. Additionally, we consulted with a certified pathologist to investigate future improvements. We anticipate this work to inspire the application of zero-shot diffusion models in computational pathology, providing an efficient method to generate in-silico images with unmatched fidelity and realism, which prove meaningful for downstream tasks, such as training existing deep learning models or finetuning foundation models.
△ Less
Submitted 15 January, 2025; v1 submitted 16 July, 2024;
originally announced July 2024.
ReStainGAN: Leveraging IHC to IF Stain Domain Translation for in-silico Data Generation
Authors:
Dominik Winter,
Nicolas Triltsch,
Philipp Plewa,
Marco Rosati,
Thomas Padel,
Ross Hill,
Markus Schick,
Nicolas Brieu
Abstract:
The creation of in-silico datasets can expand the utility of existing annotations to new domains with different staining patterns in computational pathology. As such, it has the potential to significantly lower the cost associated with building large and pixel precise datasets needed to train supervised deep learning models. We propose a novel approach for the generation of in-silico immunohistoch…
▽ More
The creation of in-silico datasets can expand the utility of existing annotations to new domains with different staining patterns in computational pathology. As such, it has the potential to significantly lower the cost associated with building large and pixel precise datasets needed to train supervised deep learning models. We propose a novel approach for the generation of in-silico immunohistochemistry (IHC) images by disentangling morphology specific IHC stains into separate image channels in immunofluorescence (IF) images. The proposed approach qualitatively and quantitatively outperforms baseline methods as proven by training nucleus segmentation models on the created in-silico datasets.
△ Less
Submitted 11 March, 2024;
originally announced March 2024.
